Acetamide,N,N'-(2-hydroxy-1,3-propanediyl)bis[2-iodo-

Suppliers

Names

[ CAS No. ]:
64049-32-7

[ Name ]:
Acetamide,N,N'-(2-hydroxy-1,3-propanediyl)bis[2-iodo-

[Synonym ]:
S 36
ACETAMIDE,N,N'-(2-HYDROXY-1,3-PROPYLENE)BIS(IODO
Acetamide,N'-(2-hydroxy-1,3-propanediyl)bis[2-iodo
N,N'-(2-Hydroxy-1,3-propylene)bis(iodoacetamide)
LS-9755

Chemical & Physical Properties

[ Density]:
2.224g/cm3

[ Boiling Point ]:
626.6ºC at 760mmHg

[ Molecular Formula ]:
C7H12I2N2O3

[ Molecular Weight ]:
425.99100

[ Flash Point ]:
332.8ºC

[ Exact Mass ]:
425.89400

[ PSA ]:
78.43000

[ LogP ]:
0.23150

[ Index of Refraction ]:
1.641

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
AC3862000
CHEMICAL NAME :
Acetamide, N,N'-(2-hydroxy-1,3-propylene)bis(iodo-
CAS REGISTRY NUMBER :
64049-32-7
LAST UPDATED :
199201
DATA ITEMS CITED :
2
MOLECULAR FORMULA :
C7-H12-I2-N2-O3
MOLECULAR WEIGHT :
426.01
WISWESSER LINE NOTATION :
I1VM1YQ1MV1I

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
15 mg/kg
TOXIC EFFECTS :
Behavioral - convulsions or effect on seizure threshold Lungs, Thorax, or Respiration - acute pulmonary edema Skin and Appendages - dermatitis, other (after systemic exposure)
REFERENCE :
JNCIAM Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. Volume(issue)/page/year: 31,297,1963
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Mammal - dog
DOSE/DURATION :
2900 ug/kg
TOXIC EFFECTS :
Lungs, Thorax, or Respiration - acute pulmonary edema Lungs, Thorax, or Respiration - dyspnea Lungs, Thorax, or Respiration - other changes
REFERENCE :
JNCIAM Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. Volume(issue)/page/year: 31,297,1963

Related Compounds

  • 3-[4-(2,6-difluorobenzoyl)piperazin-1-yl]-6-(1H-pyrazol-1-yl)pyridazine
  • (4-(6-(1H-pyrazol-1-yl)pyridazin-3-yl)piperazin-1-yl)(2-chloro-6-fluorophenyl)methanone
  • 3-(1H-pyrazol-1-yl)-6-{4-[2-(trifluoromethyl)benzoyl]piperazin-1-yl}pyridazine
  • 3-(1H-pyrazol-1-yl)-6-{4-[3-(trifluoromethyl)benzoyl]piperazin-1-yl}pyridazine
  • 3-(1H-pyrazol-1-yl)-6-{4-[4-(trifluoromethyl)benzoyl]piperazin-1-yl}pyridazine
  • (4-(6-(1H-pyrazol-1-yl)pyridazin-3-yl)piperazin-1-yl)(naphthalen-2-yl)methanone
  • (4-(6-(1H-pyrazol-1-yl)pyridazin-3-yl)piperazin-1-yl)([1,1'-biphenyl]-4-yl)methanone
  • 1-(4-(6-(1H-pyrazol-1-yl)pyridazin-3-yl)piperazin-1-yl)-2-phenoxyethanone
  • 1-(4-(6-(1H-pyrazol-1-yl)pyridazin-3-yl)piperazin-1-yl)-2-phenylethanone
  • 1-(4-(6-(1H-pyrazol-1-yl)pyridazin-3-yl)piperazin-1-yl)-3-phenylpropan-1-one
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.